$ASEP ASEP Medical Holdings $ASEP/$ASEP.C seeing some price correction after prices took an 80% run from recent lows after IPO. With support appearing to have been established at $.43, I’ll be keeping a close eye for a retest of this zone, should shares continue on a downward trajectory.
Some things I’ll be watching for to provide a bullish catalyst for $ASEP are announcements on its two products currently in production. With products including a diagnostic technology for the early identification of sepsis infections, there is huge potential for $ASEP to seize a share of the market expected to grow at a CAGR of 8.5% from a current market value of $1B.
With $ASEP’s other breakthrough product offering treatment of otherwise antibiotic-resistant biofilm infections, the company is setting itself up to solve some serious problems affecting medical treatment right now.
Products are currently in pre-clinical development but are expected to progress quickly. I’m staying bullish on $ASEP and I am keeping alerts set for any and all news about the development of its sepsis and biofilm solutions.
$ASEP is currently trading at $.6 and is valued at an MCAP of $33.68 million.
https://asepmedical.com/investors/